Drugs / PepGNP-ChikV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07394426 | Aug 2026 → Dec 2027 expected | chikungunya | Gylden Pharma Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PepGNP-ChikV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07394426 ↗ |
| Route | Other | “PepGNP-ChikV vaccine will be administered by an intradermal microneedle device” NCT07394426 ↗ |